Sydney, Australia – October 24th, 2024 – SpeeDx, a leading innovator in molecular diagnostic solutions, today announced the appointment of Jeremy Stackawitz as Chief Executive Officer. With more than 25...
EntericPlex* products Sharpen Your Focus SpeeDx have released a suite of gastroenteritis panels, the three EntericPlex RUO assays, each with up to 5 targets in a single-well multiplexed qPCR/NAAT assay⎯differing from...
Upfront diagnosis. Combat seasonal testing surges with ease PlexPCR® Flu/RSV/SARS-CoV-2 detects Influenza, Respiratory Syncytial Virus and SARS-CoV-2 virus in a single-well multiplex qPCR test. Prompt identification of these viral infections can...
SpeeDx Pty. Ltd., have released a new Research Use Only (RUO) product providing an exciting expansion of their research offering. CT/GC/TV/MGPlex* simultaneously detects Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), Trichomonas...
Partnership with Biosapientia expands SpeeDx product availability in France SYDNEY, AUSTRALIA – (May 17, 2023). SpeeDx have announced signing a new distribution partner, further extending access for customers to market leading...
Funds will accelerate technology development to increase actionable patient results per test SYDNEY Australia 28 February 2023, SpeeDx Pty. Ltd., a developer of transformative molecular diagnostic solutions, has today announced...
Adjunct Professor Alison Todd and Dr Elisa Mokany have received the Prime Minister’s Prize for Innovation in the 2022 Prime Minister’s Prizes for Science. The pair are recognised for their...
SpeeDx Awarded REDI Fellowship to Support the development of Next Generation detection of Chlamydia trachomatis and Neisseria gonorrhoeae In collaboration with researchers at The University of Technology Sydney, focusing on...
Provision of SARS-CoV-2 tests reinforces PNG sovereign capacity to respond to ongoing pandemic. SpeeDx announce they have donated PlexPCR® SARS-CoV-2 tests and PlexPrime® SARS-CoV-2 Genotyping reagents to support Papua New Guinea...
